BioSpace News Archive

TradersEXPO New York to be Attended by Accredited Individual Investors, Institutional Investors, and Investment Banking Firms NEW YORK, NY, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it ha

INDIANAPOLIS , Feb. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition expands Lilly’s immunology pipeline with the addition of lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 with high affinity that is being evaluated in a Ph

Feb. 20, 2020 13:49 UTC DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- IQVIA™ (NYSE: IQV), a leader in human data science, today announced the launch of Avacare Clinical Research Network™, a technology-based global site network that opens opportunities for more clinical trials at experienced clinical and research sites. Avacare’s unique analytical tools help sites in Avacare’s network match patients to clinical trials faster and more effectively. “We b

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Siegfried Reich, Ph.D. as executive vice president and chief scientific officer effective March 2. Dr. Reich has over 25 years of pharmaceutical and biotech experience developing more than 20 drug candidates, including the approved drugs Viracept® for HIV and the

MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza® (insulin human) Inhalation Powder and MannKind’s BluHale® technology system.

Tufts Health Freedom Plan announced the expansion of its telehealth virtual health care solution.

Feb. 20, 2020 14:00 UTC Products within the SigNature ® and CertainT ® Brand Certified in Strict Compliance with OU Standards as Ingredients for Dietary Supplements, Pharmaceuticals and Food Products STONY BROOK, N.Y.--( BUSINESS WIRE )-- Applied DNA Sciences , Inc. (“Applied DNA”, the “Company”, NASDAQ: APDN), announced receipt of certification from the Orthodox Union (OU ® ) for products within the SigNature and CertainT line following a thorough evaluation of the Compa

Feb. 20, 2020 14:00 UTC WILMINGTON, N.C.--( BUSINESS WIRE )-- PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced it will release its fourth quarter and full year 2019 results and issue full year 2020 guidance after market close on Wednesday, March 4, 2020. The earnings release and accompanying financial information will be available on the investors section of PPD’s website at https://investors.ppdi.com . The release will be followed by a con

Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company’s CE-marked Peregrine System™ Infusion Catheter were published in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Verrica Pharmaceuticals Inc. announced that Ted White, Verrica President and CEO, will attend several upcoming investor conferences in March.